Stockscreener 앱 받기
0.99
12.39%
-0.14
Silo Pharma Inc 주식(SILO)의 최신 뉴스
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders - The Manila Times
Silo Pharma reports progress in PTSD treatment study - Investing.com
Silo Pharma Third Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.21 loss in 3Q 2023) - Yahoo Finance
SILOSilo Pharma, Inc. Latest Stock News & Market Updates - StockTitan
Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - GlobeNewswire
Silo Pharma, Inc. Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - Marketscreener.com
Micron Technology (MU-Q) QuotePress Release - The Globe and Mail
Orange Juice (OJX25) Quote - The Globe and Mail
Japan Ice Bank Silo Market By Application - Third Eye News
SILO Pharma (NASDAQ:SILO) Stock Quotes, Forecast and News Summary - Benzinga
Exclusive Come Home Trailer Previews Horror Thriller Movie Featuring Silo Stars - ComingSoon.net
Egypt: General Company for Silos’s profits rise 45.6% YoY in FY2023/24 - ZAWYA
Silvis Materials Awarded $1 Million NSF SBIR Phase II Grant to Reduce Emissions in Packaging and Building - EIN News
FDA Grants Accelerated Approval to Gilead’s Livdelzi for Primary Biliary Cholangitis - The Healthcare Technology Report.
Serpin Pharma and Uniklinikum Erlangen Team Up for a Clinical Trial to Prevent Acute Kidney Injury - EIN News
New Silo Season 2 Character Is Very Closely Copying An Iconic 2000s TV Show - Screen Rant
Roli Mosimann (Swans / Wiseblood / The The) has died - Brooklyn Vegan
SosMula Finally Delivers "SLEEZ RELIGION" - HotNewHipHop
Silo season 2: Apple TV Plus release date, likely cast, story rumors, and more news about the sci-fi show's return - TechRadar
Silo Pharma completes pre-IND meeting with FDA on SPC-15 for PTSD - BioWorld Online
Financial Metrics Exploration: Understanding SILO Pharma Inc (SILO) Through Ratios - The Dwinnex
SILO Pharma Inc [SILO] Insider Activity: An Update for Investors - Knox Daily
Silo Pharma moves forward with PTSD treatment SPC-15 - Investing.com
Silo Pharma moves forward with PTSD treatment SPC-15 By Investing.com - Investing.com Australia
SILO Pharma Inc Inc. (SILO) Price Performance: A Technical Analysis Perspective - The InvestChronicle
SILO’s price-to-sales ratio: Is it a good investment opportunity? - US Post News
Silo Pharma Outlines Strategic Direction and Innovative Pipeline - TipRanks
Silo Pharma Announces Completion of FDA Pre-IND Meeting to - GlobeNewswire
Psychedelic Drugs Market to Grow by USD 1.37 Billion from 2024-2028, Driven by Increasing Mental Health Disorders, Report Highlights AI's Impact on the Market LandscapeTechnavio - The Malaysian Reserve
Silo Pharma (NASDAQ:SILO) Shares Down 6% - Defense World
Adversity is less terrifying than hope: SILO Pharma Inc (SILO) - SETE News
SILO Pharma Inc (SILO)’s stock price range in the last year - US Post News
Metric Deep Dive: Understanding SILO Pharma Inc (SILO) Through its Ratios - The Dwinnex
SILO Pharma Inc [SILO] Investment Guide: What You Need to Know - Knox Daily
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million - Quantisnow
SILO’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Silo Pharma advances ketamine implant for chronic pain treatment - Investing.com India
Silo Pharma Shares Jump 11% on Ketamine-Treatment Partnership - MarketWatch
Silo Pharma advances ketamine implant for chronic pain treatment By Investing.com - Investing.com UK
Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic - GlobeNewswire
SILO Pharma Inc’s latest rating changes from various analysts - Knox Daily
Silo Pharma partners with WuXi AppTec for MS peptide study - Investing.com India
Closing Figures: SILO Pharma Inc (SILO)’s Negative Finish at 1.18, Down -13.24 - The Dwinnex
Silo Pharma partners with WuXi AppTec for MS peptide study By Investing.com - Investing.com UK
SILO’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
How does SILO’s price to cash per share ratio compare in the market? - US Post News
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide - GlobeNewswire
Taking on analysts’ expectations and winning: SILO Pharma Inc (SILO) - SETE News
Examining SILO Pharma Inc (SILO) more closely is necessary - US Post News
Investing in SILO Pharma Inc (SILO): What You Must Know - Knox Daily
SILO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Financial Metrics Unveiled: SILO Pharma Inc (SILO)’s Key Ratios in the Spotlight - The Dwinnex
Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference - GlobeNewswire
SILO Pharma Inc [SILO] CEO and President makes an insider purchase of 4,438 shares worth 4926.0. - Knox Daily
Financial Fitness Check: Examining SILO Pharma Inc (SILO)’s Key Ratios - The Dwinnex
ADIL Stock A Beacon of Hope: A Deep Dive into Adial Pharmaceuticals - All Finance Times
How does SILO Pharma Inc (SILO) change from a tortoise to a hare? - SETE News
Understanding the Risks of Investing in SILO Pharma Inc (SILO) - Knox Daily
3.66%
1.11%
자본화:
|
볼륨(24시간):